Keywords: bayer, profit, climbs, stockholders, gain, agfa, flotation
Bayer profit climbs 24% in 1999; stockholders to gain from Agfa flotation
Article | 09 March 2000
As the Marketletter went to press, Bayer reported group sales in 1999 of27.32 billion euros ($26.55 billion), down marginally on the 28.06 billion ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Proposal to list Roche's Neulastim and Actemra in New Zealand
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
